[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-350816-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-350816-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","cytokine-regulation-of-the-bone-pre-and-metastatic-niches-implications-for-breast-cancer-dormancy-review","Cytokine Regulation of the Bone Pre-and Metastatic Niches: Implications for Breast Cancer Dormancy - Review","","Breast cancer relapse in bone is a major clinical problem affecting roughly 70–80% of patients with late-stage disease, often appearing 5–10+ years after primary tumor removal. Tumor cell dormancy explains the long latency, with interactions between disseminated cancer cells and bone metastatic niches maintaining cells in a quiescent state until niche changes enable reactivation and outgrowth. Cytokines regulate bone homing and niche expansion, including proinflammatory and bone-associated factors that drive a feedback “vicious cycle” of metastasis.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/cytokine-regulation-of-the-bone-pre-and-metastatic-niches-implications-for-breast-cancer-dormancy-review/350816/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/cytokine-regulation-of-the-bone-pre-and-metastatic-niches-implications-for-breast-cancer-dormancy-review/350816.png","ImageObject",300,407,{"name":42,"@type":43},"pixelkiddo","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-23","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",11,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Why does breast cancer relapse in bone have a long latency after treatment?","Question",{"text":63,"@type":64},"The long delay is attributed to tumor cell dormancy. Disseminated cells remain quiescent in bone metastatic niches until local environmental changes reactivate them.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"Which cytokine-related signals are described as supporting bone homing and dormancy?",{"text":68,"@type":64},"Macrophage polarization and CXCL9, CXCL10, and CXCL12 signaling support bone homing and dormancy. Cytokines such as LIF, TGF-β, BMP, FGF, and interleukins help maintain disseminated tumors in a dormant state.",{"name":70,"@type":61,"acceptedAnswer":71},"How does cytokine regulation relate to metastatic outgrowth in bone?",{"text":72,"@type":64},"Interactions between cancer cells and the metastatic niche disrupt the immune and cytokine landscape, enabling tumor re-awakening and subsequent metastatic outgrowth. The review links cytokine signaling cascades to niche expansion and escape from dormancy.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},350816,1790392790,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":140,"language":141,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":12,"update_tm":145,"read_time":146,"preview_page_count":33,"preview_urls":147},962090883892,"https://ap-avatar.wpscdn.com/avatar/e00115db34f3e0f11b?x-image-process=image/resize,m_fixed,w_180,h_180&k=1790152879550218658","Review  \nCytokine Regulation of the Bone Pre-and Metastatic Niches: Implications for Breast Cancer Dormancy  \nTamara A. Clover 1, Maria L. Price 1, Lewis A. Quayle 2, Christine L. Le Maitre 1 and Penelope D. Ottewell 1, *  \nAcademic Editors: Afshan Fathima Nawas and Jaehong Kim  \nReceived: 18 July 2026  \nRevised: 14 August 2026  \nAccepted: 20 August 2026  \nPublished: 25 August 2026  \nCopyright: © 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.  \n1 Division of Clinical Medicine, University of Sheffield, Beech Hill Road, Sheffield S10 2RX, UK;  \ntaclover1@sheffield.ac.uk (T.A.C.); m.l.price@sheffield.ac.uk (M.L.P.); c.lemaitre@sheffield.ac.uk (C.L.L.M.)  \n2 School of Biosciences and Chemistry, Sheffield Hallam University, Howard St, Sheffield S1 1WB, UK; [l.quayle@shu.ac.uk](l.quayle@shu.ac.uk)  \n* [Correspondence: p.d.ottewell@sheffield.ac.uk](Correspondence: p.d.ottewell@sheffield.ac.uk)  \nHighlights  \nWhat are the main findings?  \n• Macrophage polarisation, CXCL9, 10 and 12 signalling support bone homing and dormancy of breast cancer. Cytokines LIF, TGF-β, BMP, FGF and interleukins maintain bone disseminated breast tumours in a dormant state.  \n• Within the bone, interactions between cancer cells and the metastatic niche disrupt the immune and cytokine landscape, permitting breast tumour re-awakening and subsequent metastatic outgrowth.  \nWhat are the implications of the main findings?  \n• Understanding cytokine-mediated breast tumour relapse in the bone has led to advancements in therapeutic intervention strategies, specifically targeting dormancy maintenance and eradication mechanisms.  \n• Novel therapeutic interventions are necessary for the targeting of dormant cells to prevent late-onset metastasis.  \nAbstract  \nBreast cancer relapse in bone is a significant clinical problem that is experienced in ~70–80% of patients with late-stage breast cancer. This condition commonly occurs 5–10+ years following surgical removal of the primary tumour. The long latency seen prior to relapse in bone is a result of tumour cell dormancy. Once disseminated to the bone, tumour cell interaction with the bone metastatic niche (endosteal niche and endovascular cells) maintains cells in a dormant state until changes to the local environment activate the niche to support outgrowth. Amassing evidence suggests that cytokines are key regulators of the bone metastatic niche, controlling bone homing and metastatic outgrowth. Proinflammatory cytokines, including IL-1β, IL-6, IL-8, TGFβ and RANKL, play crucial roles in attracting tumour cells to bone. Furthermore, these cytokines act in conjunction with IFN, VEGF, TGF, PTHrP, FGF, OPG and various chemokines to regulate expansion of the niche, facilitating tumour cell escape from dormancy and promoting the “vicious cycle of bone metastasis”. Here, we review the current literature to provide an up-to-date understanding of how interactions between cytokine signalling cascades regulate the bone metastatic niches to promote homing, dormancy or metastatic outgrowth of breast cancers. Because breast cancers are predominantly osteolytic, this review focuses on dormancy and metastatic outgrowth associated with lytic disease in addition to current advances in novel therapeutics aimed at preventing this condition through targeting dormant cells.  \nKeywords: breast cancer; bone metastasis; pre-metastatic niche; metastatic niche; dormancy; cytokine regulation  \n1. Introduction  \nFemale breast cancer is the second most common cancer diagnosed worldwide, with 666,000-reported deaths in 2022 [1] . Strikingly, the greatest cause of death in breast cancer patients is metastasis rather than the primary tumour itself [2], with 70–80% of late-stage breast cancer patients developing incurable bone metastases [3] .  \nWithin the bone, breast cancer cells have been found to home to the","cbCain4w5GIz1pw1","https://ap.wps.com/l/cbCain4w5GIz1pw1","pdf",2682566,28,"English","# Highlights\n## What are the main findings?\n## What are the implications of the main findings?\n# Abstract\n# Keywords\n# 1. Introduction","[{\"question\":\"Why does breast cancer relapse in bone have a long latency after treatment?\",\"answer\":\"The long delay is attributed to tumor cell dormancy. Disseminated cells remain quiescent in bone metastatic niches until local environmental changes reactivate them.\"},{\"question\":\"Which cytokine-related signals are described as supporting bone homing and dormancy?\",\"answer\":\"Macrophage polarization and CXCL9, CXCL10, and CXCL12 signaling support bone homing and dormancy. Cytokines such as LIF, TGF-β, BMP, FGF, and interleukins help maintain disseminated tumors in a dormant state.\"},{\"question\":\"How does cytokine regulation relate to metastatic outgrowth in bone?\",\"answer\":\"Interactions between cancer cells and the metastatic niche disrupt the immune and cytokine landscape, enabling tumor re-awakening and subsequent metastatic outgrowth. The review links cytokine signaling cascades to niche expansion and escape from dormancy.\"}]","Cytokine Regulation of the Bone Pre-and Metastatic Niches: Implications for Breast Cancer Dormancy - Review | PDF",1790091269,71,[148,152,156,160],{"page_no":22,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/de434bc495af18955136787dc8ba145f.webp",983,1390,{"page_no":26,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7315207839ad28e1166640f7c3d24464.webp",982,1388,{"page_no":30,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0ad08337547c68cfc8ba2854f3ea62e6.webp",981,1387,{"page_no":33,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7cc02d065772b613f6ea21e308825ae0.webp",980,1385]